SCHEMBL30899286

SCHEMBL30899286

Cc1ccc(-c2nnc(-c3ccccc3)[nH]2)cc1S(=O)(=O)N1CCOCC1CO

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 8/20 0.43
CNR2 P34972 8/20 0.43
MAPT P10636 5/20 0.40
TP53 P04637 2/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
KDM4E B2RXH2 2/20 0.38
LMNA P02545 2/20 0.38
HPGD P15428 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
THRB P10828 1/20 0.38
GAA P10253 1/20 0.38
ALDH1A1 P00352 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24512135 1.00 CNR1 (0.43) CNR1CNR2MAPTTP53SMN1; SMN2
SCHEMBL24512273 0.87 CNR1 (0.46) CNR1CNR2MAPTTP53SMN1; SMN2
SCHEMBL30899272 0.87 CNR1 (0.46) CNR1CNR2MAPTTP53SMN1; SMN2
SCHEMBL29717111 0.80 CNR1 (0.64) CNR1CNR2MAPTTP53SMN1; SMN2
SCHEMBL24512245 0.80 CNR1 (0.64) CNR1CNR2MAPTTP53SMN1; SMN2
SCHEMBL24512359 0.78 CNR1 (0.46) CNR1CNR2MAPTTP53SMN1; SMN2
SCHEMBL24512121 0.78 CNR1 (0.46) CNR1CNR2MAPTTP53SMN1; SMN2
SCHEMBL24512143 0.77 MAP4K1 (0.35) CNR1CNR2LMNAHPGD
SCHEMBL24512243 0.76 CNR1 (0.41) CNR1CNR2MAPTSMN1; SMN2KDM4E
SCHEMBL29717158 0.76 CNR1 (0.41) CNR1CNR2MAPTSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117915903-A Compounds for the treatment of neurodegenerative, degenerative and metabolic disorders and uses thereof 佛罗里达大学研究基金会公司 2024-04-19 CN disclosed